Optober , News Flow , MND , K9 Cancer

Incredible that 2 years have flown by since the Recognition and Reward Options were marketed.

The climb required now is steep but certainly not impossible as Biotech is the most volatile sector on the ASX.

Catalysts are on the near horizon , MND Data analysis must almost be completed , Confirmation of Cohort 1,2,3 completion now only requires the final data from Cohort 4 to be added to the final data analysis.

Certainly every indication points to the completion of the Human Phase I/II MND Trial to be positive, given updates have quoted "Stable Disease"

Bucklands data surrounding survival times was impressive , especially for those Trial Patients that had been diagnosed a year prior to undertaking the trial , some of the Trial Patients have been actually taking MPL now for 20 months.
The 36 month life expectancy is a "best case Scenario" regrettably I know a guy in NZ that from diagnosis to passing on was only 9 months and the last months are not pleasant, this disease leaves the patient cognitive but trapped within their own failing and non responsive body..

The current FDA Approved treatments are rife with Serious Adverse Effects and "Only Deliver" small life extension and that life extension does not deliver any Quality of Life.. QOL is everything, it really is only survival not living at all.



I would like to personally thank the Trial Patients for their participation in the actual trial itself, from reading the ANZCTR the Trial Patients give up a considerable amount of time "Truly Valuable Time" to have bloods taken at multiple regular intervals and undertake cognitive testing etc.
I can only commend those participating in the Trial , your bravery and selfless actions may well bring an end to this devastating disease.

The only way to reward these efforts is to bring MPL to the front of thinking, this will require a concerted effort on multiple fronts to promote MPL into the mainstream media , then a Social Media campaign to compliment the mainstream then a solid push to actual Investors, ASX participants as future funding needs to be secured on the rise of awareness.. and some serious money is going to be required..

$15.2m can be raised from the Reward and Recognition Options, this is the most competitive way to raise funds as it does not require the standard 5/6% raising fees and at $60k per million = $900k in raising fees , plus usually a slab of free shares as well........

What I have not seen is a significant shift in messaging over the past 2 years to promote the company and the incredible data that has been gained from Trial ,after Trial ,after Trail , after Trial.

PAA can not continue to survive in the shadows any longer, Meeting with other investors and Traders once a month many have stated to me that PAA is not an Investment Target because it has not shown a return to any SH over a 9 year period, the SP is flat with only 1 Catalyst that was Covid.
PAA has a market reputation as a Research Institute and from some a Lifestyle Company for the BOD..

PAA to throw the shroud of being a non profit needs to FOCUS on promoting the Investment Opportunity, there are currently 197 Biotechs and Baby Pharma on the ASX , PAA are competing for Investment/ Finance and at present are doing a very poor job of 1, changing perception, 2 Actually Delivering a return , 3 not providing any liquidity which many investors require and other Biotechs are delivering.

When the final results from the MND Trial are released I would expect this time to see a market reaction..
For those that use the line "It will sell itself" how wrong you are in todays world of Paid Content.. Until PAA Management understand they have been failing miserably on 'One Critical Discipline" Messaging , Communication , Imparting Value , imparting that there is money to be made here then we can only expect the market to react to those that ACTIVELY promote those facets of an investment..

And we are all invested here ,, and we all want a return whilst we have the ability to enjoy said return on Investment...

Many promises have been made in previous announcements.

Now is the time to deliver,,, with the Cost of Living Crisis effecting the majority of Investors this Christmas is looking to be the largest exit in Retail Investors in decades,, stats are point to already 47% of retail investors have sold or are selling down investments in the ASX..

PAA Management need to be extremely mindful that they have had significant over runs on delivery times and have not shown a return to SH .

PAA is solely SH funded and now that Epichem has been liquidated the burden on SH will be even greater going forward..

Why has a Trader stayed the line ,
1 I have already made a return , I sold a Million shares up @20c
2, MPL is no same same drug , it's not another Treatment for a rudimentary illness in a heavily populated market with a different sleeve or packet.
3, Value , the value of "Disruptive Technology" is hugely significant , literally the difference between cut glass and Diamonds.
4 There is a Significant Market Waiting for MPL to be commercialised

Now is the time for Management to deliver , My timeline for a significant change in Company Value is Prior to Christmas , multiple significant Catalysts have the ability to deliver and increase in SH Value,,, what will be on show now is Managements ability and effort or even desire to promote MPL ,PAA's Investment Opportunity to actual Investors...
The last 2 years have been absolutely atrocious with Management not only not pushing the Promotion Button but ignoring the fact we are SH , we are Investors,,, Not Donors... Now is the time for Significant Change ..or PAA will have considerable funding difficulty moving forward....NZT